BrainStorm Cell Therapeutics Inc (BCLI)

[midastouch017]

BrainStorm Cell Therapeutics to Announce Third Quarter Results and Provide a Corporate Update

https://finance.yahoo.com/news/brainstorm-cell-therapeutics-announce-third-211000112.html

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will hold a conference call to update shareholders on financial results for the third quarter ended September 30, 2022, and provide a corporate update, at 8:00 a.m. Eastern Time on Monday, November 14, 2022.

BrainStorm's Chief Executive Officer, Chaim Lebovits, will present a corporate update after which participant questions will be answered. Joining Mr. Lebovits to answer investment community questions will be Ralph Kern, MD, MHSc, President and Chief Medical Officer, Stacy Lindborg, PhD, Executive Vice President and Chief Development Officer, David Setboun, PharmD, MBA, Executive Vice President and Chief Operating Officer, and Alla Patlis, CPA, MBA, Interim Chief Financial Officer.

Participants are encouraged to submit their questions in advance of the call by sending them to: [e-mail]. Questions should be submitted by 5:00 p.m. Eastern Time on Thursday November 10, 2022.

The investment community may participate in the conference call by dialing the following numbers:

Participant Numbers:
Toll Free: 877-545-0523
International: 973-528-0016
Entry Code: 710870

Webcast URL: https://bit.ly/3AeRBkr

Those interested in listening to the conference call live via the internet may do so by using the webcast link above or by visiting the "Investors & Media" page of BrainStorm's website here and clicking on the conference call link.

The replay of the conference call can be accessed by dialing the numbers below, and will be available for 14 days.

Replay Numbers:
Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 47063